Defining the mechanism of action of 4-phenylbutyrate to develop a small-molecule-based therapy for Alzheimer's disease.
4-phenylbutyrate (PBA) is a small molecule that restores cognitive deficits in animal models of Alzheimer's disease (AD). Although the molecular basis of the cognitive benefits of PBA remains unknown, a multi-modal/multi-target mechanism has been proposed. Putative targets of this drug are diff...
Main Authors: | Cuadrado-Tejedor, M. (Mar), Garcia-Osta, A. (Ana), Ricobaraza, A. (Ana), Oyarzabal, J. (Julen), Franco, R. (Rafael) |
---|---|
格式: | info:eu-repo/semantics/article |
語言: | eng |
出版: |
Bentham Science Publ LTD
2012
|
主題: | |
在線閱讀: | https://hdl.handle.net/10171/23299 |
相似書籍
-
Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology
由: Escribano, L. (Luis), et al.
出版: (2010) -
Chronic mild stress accelerates the onset and progression of the Alzheimer's disease phenotype in tg2576 mice
由: Cuadrado-Tejedor, M. (Mar), et al.
出版: (2012) -
Estudio de las principales vías responsables del efecto terapéutico del sildenafilo sobre el deterioro cognitivo del ratón de senescencia acelerada SAMP8
由: Orejana, L. (Lourdes), et al.
出版: (2014) -
Synergistic effect of novel HDAC inhibitors with chemotherapy drugs in acute myeloid leukemia
由: Giménez-Camino, N. (Naroa), et al.
出版: (2022) -
Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease
由: Garcia-Osta, A. (Ana), et al.
出版: (2012)